Association between an insertion/deletion polymorphism within 3′UTR of SGSM3 and risk of hepatocellular carcinoma

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 295-301

  Wang, Chaoqun ^a   Zhao, Hua ^b   Zhao, Xiankun ^a   Wan, Jiao ^a   Wang, Dayong ^c   Bi, Wanli ^c   Jiang, Xinghong ^a   Gao, Yuzhen ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Nuhigh Biotechnology   (China)

Author keywords

Hepatocellular carcinoma; microRNA 151 5p; rs56228771; SGSM3

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN; SMALL G PROTEIN SIGNALING MODULATOR 3; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER RISK; CANCER TISSUE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATOMA CELL; HUMAN; IN VITRO STUDY; INDEL MUTATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RNA BINDING;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; BASE PAIRING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEOPLASM STAGING; POLYMORPHISM, GENETIC; RISK; RNA INTERFERENCE;

EID: 84893764236     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1039-x     Document Type: Article

References (26)

1. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448-58.
2. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis. 2011;15:223-43.
3. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol. 2001;28:441-9.
4. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286:9-14.
5. Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52:252-7.
6. Chen CJ, Chen DS. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002;36:1046-9.
7. Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:477-83.
8. Yang H, Sasaki T, Minoshima S, Shimizu N. Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway. Genomics. 2007;90:249-60.
9. Lee IK, Kim KS, Kim H, Lee JY, Ryu CH, Chun HJ, et al. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain. Biochem Biophys Res Commun. 2004;325:774-83.
10. Li G. Rab GTPases, membrane trafficking and diseases. Curr Drug Targets. 2011;12:1188-93.
11. Chia WJ, Tang BL. Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta. 2009;1795:110-6.
12. Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 2010;24:1718-30.
13. Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis. 2009;30:2064-9.
14. Zhu Z, Gao X, He Y, Zhao H, Yu Q, Jiang D, et al. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res. 2012;72:6163-72.
15. Gao X, Huang M, Liu L, He Y, Yu Q, Zhao H, et al. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. PLoS One. 2013;8:e55169.
16. Allen RC, Graves G, Budowle B. Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques. 1989;7:736-44.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8.
18. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol. 2004;2:e363.
19. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA. 1994;91:10350-4.
20. Bose S, Sakhuja P, Bezawada L, Agarwal AK, Kazim SN, Khan LA, et al. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling. J Gastroenterol Hepatol. 2011;26:135-44.
21. Johnson SA, Mandavia N, Wang HD, Johnson DL. Transcriptional regulation of the TATA-binding protein by Ras cellular signaling. Mol Cell Biol. 2000;20:5000-9.
22. Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 2007;17:118-26.
23. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA. 2005;11:1753-61.
24. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008;29:1306-11.
25. Liu AM, Zhang C, Burchard J, Fan ST, Wong KF, Dai H, et al. Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. OMICS. 2011;15:187-91.
26. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol. 2010;12:390-9.